Terumo Blood and Cell Technologies
The Senior Director, Strategic Platform Execution leads a global organization responsible for bringing TerumoBCT's devices, disposables, and software to market. Reporting to the Senior Vice President of R&D, the role oversees planning, prioritization, and delivery across multiple sites, and serves as the senior R&D voice on product strategy and execution.
Headquarters
Lakewood, Colorado, United States
Company Size
5001-10000 employees
Founded
1964
Terumo Blood and Cell Technologies is a global medical technology company that develops and manufactures solutions for blood collection, processing, and pathogen reduction, as well as therapeutic apheresis and cell therapy technologies. Their product portfolio includes automated blood collection and processing systems, apheresis platforms, cell expansion systems, and supporting software and services. The company serves blood centers, hospitals, and cell therapy manufacturers worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Terumo Blood and Cell Technologies.
Terumo Blood and Cell Technologies didn’t post a salary, so this is our estimate from similar listings.
24% below the average for this role
VP R&D, Rare Disease
AstraZeneca
Sr. Manager, Strategic R&D Operations
Solventum
Vice President Vaccine Development
Ceva Animal Health
Vice President, Global Commercial Strategy Internal Medicine & Antivirals Lead
Pfizer
R&D Portfolio & PMO Manager
Innovation Concrete Laboratory
Director of Research & Development – Portfolio Management
balchem